233 related articles for article (PubMed ID: 33660221)
1. Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz T; Biragyn A; Frenkel-Morgenstern M; Weissberg O; Gorohovski A; Merzon E; Green I; Iulita F; Flores-Aguilar L; Dierssen M; De Toma I; Lifshitz H; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; Sarid R; London J; Mobley W; Strydom A; Okun E
Neuromolecular Med; 2021 Dec; 23(4):561-571. PubMed ID: 33660221
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series.
Villani ER; Carfì A; Di Paola A; Palmieri L; Donfrancesco C; Lo Noce C; Taruscio D; Meli P; Salerno P; Kodra Y; Pricci F; Tamburo de Bella M; Floridia M; Onder G;
Am J Med Genet A; 2020 Dec; 182(12):2964-2970. PubMed ID: 32918520
[TBL] [Abstract][Full Text] [Related]
3. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
De Toma I; Dierssen M
Sci Rep; 2021 Jan; 11(1):1930. PubMed ID: 33479353
[TBL] [Abstract][Full Text] [Related]
4. Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients.
Newman AM; Jhaveri R; Patel AB; Tan TQ; Toia JM; Arshad M
J Pediatr; 2021 Jan; 228():294-296. PubMed ID: 32861693
[TBL] [Abstract][Full Text] [Related]
5. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies.
Foxworthy B; Dai C; Davis EC; Xavier AC; Brackett J; Dickens D; Kahn A; Martinez I; Sharma A; Schwalm C; Foley J; Wilkes J; ; Bhatia S; Levine JM; Johnston EE; Wolfson JA
Pediatr Blood Cancer; 2024 Aug; 71(8):e31082. PubMed ID: 38804869
[TBL] [Abstract][Full Text] [Related]
7. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 vaccine humoral response in adults with Down syndrome.
Sali M; Carfì A; Di Paola A; Pereyra Boza M; Zampino G; Sanguinetti M; Landi F; Onder G
Clin Microbiol Infect; 2022 Aug; 28(8):1155.e1-1155.e4. PubMed ID: 35461998
[TBL] [Abstract][Full Text] [Related]
9. Understanding COVID-19 in Africa.
Tessema SK; Nkengasong JN
Nat Rev Immunol; 2021 Aug; 21(8):469-470. PubMed ID: 34168345
[TBL] [Abstract][Full Text] [Related]
10. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
[TBL] [Abstract][Full Text] [Related]
11. Will SARS-COV-2 infection accelerate the incidence of Alzheimer's disease in Down syndrome population?
Barišić A; Vraneković J
Aging Clin Exp Res; 2022 Nov; 34(11):2919-2920. PubMed ID: 36266381
[No Abstract] [Full Text] [Related]
12. Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.
Illouz T; Biragyn A; Iulita MF; Flores-Aguilar L; Dierssen M; De Toma I; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; London J; Mobley W; Strydom A; Okun E
Front Immunol; 2021; 12():621440. PubMed ID: 34248930
[TBL] [Abstract][Full Text] [Related]
13. Vaccination and COVID-19 Dynamics in Dialysis Patients.
El Karoui K; Hourmant M; Ayav C; Glowacki F; Couchoud C; Lapidus N;
Clin J Am Soc Nephrol; 2022 Mar; 17(3):395-402. PubMed ID: 35144970
[TBL] [Abstract][Full Text] [Related]
14. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease.
Malle L; Gao C; Hur C; Truong HQ; Bouvier NM; Percha B; Kong XF; Bogunovic D
Genet Med; 2021 Mar; 23(3):576-580. PubMed ID: 33060835
[TBL] [Abstract][Full Text] [Related]
15. Causes of mortality among adults with Down syndrome before and after the COVID-19 pandemic in Spain.
Sánchez Moreno B; Adán-Lirola L; Rubio-Serrano J; Real de Asúa D
J Intellect Disabil Res; 2024 Feb; 68(2):128-139. PubMed ID: 37779228
[TBL] [Abstract][Full Text] [Related]
16. Atypical aging in Down syndrome.
Zigman WB
Dev Disabil Res Rev; 2013; 18(1):51-67. PubMed ID: 23949829
[TBL] [Abstract][Full Text] [Related]
17. Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination.
Esparcia-Pinedo L; Yarci-Carrión A; Mateo-Jiménez G; Ropero N; Gómez-Cabañas L; Lancho-Sánchez Á; Almendro-Vázquez P; Martín-Gayo E; Paz-Artal E; Sanchez-Madrid F; Moldenhauer F; Gutiérrez-Cobos A; Real de Asúa D; Alfranca A
Clin Infect Dis; 2023 Feb; 76(3):e155-e162. PubMed ID: 35869848
[TBL] [Abstract][Full Text] [Related]
18. Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects.
Zheng J; Deng Y; Zhao Z; Mao B; Lu M; Lin Y; Huang A
Cell Mol Immunol; 2022 Feb; 19(2):150-157. PubMed ID: 34645940
[TBL] [Abstract][Full Text] [Related]
19. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
Elife; 2023 Jan; 12():. PubMed ID: 36692910
[TBL] [Abstract][Full Text] [Related]
20. [Consensus of the Genetics Branch of the Chilean Society of Pediatrics on the prioritization of people with Down syndrome and rare diseases for vaccination against SARS-CoV-2].
Faundes V; Pardo R; Cammarata-Scalisi F; Alarcon P; Lay-Son G; San Martin E
Andes Pediatr; 2021 Apr; 92(2):309-315. PubMed ID: 34106172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
